Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wound Healing | 24 | 2025 | 477 | 4.540 |
Why?
|
| Interleukin-10 | 11 | 2023 | 187 | 3.320 |
Why?
|
| Neovascularization, Physiologic | 10 | 2025 | 213 | 2.290 |
Why?
|
| Hyaluronic Acid | 7 | 2021 | 108 | 1.920 |
Why?
|
| Lignin | 3 | 2025 | 18 | 1.890 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 2025 | 145 | 1.830 |
Why?
|
| Cicatrix | 4 | 2023 | 127 | 1.720 |
Why?
|
| Fibroblasts | 8 | 2021 | 861 | 1.690 |
Why?
|
| Endothelial Progenitor Cells | 2 | 2022 | 10 | 1.230 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2025 | 444 | 1.190 |
Why?
|
| Skin | 6 | 2025 | 537 | 1.030 |
Why?
|
| Free Radical Scavengers | 1 | 2025 | 58 | 0.910 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2025 | 101 | 0.890 |
Why?
|
| Oxygen | 2 | 2025 | 572 | 0.860 |
Why?
|
| Gene Transfer Techniques | 5 | 2015 | 346 | 0.860 |
Why?
|
| Surgical Wound | 1 | 2022 | 22 | 0.750 |
Why?
|
| Wound Infection | 5 | 2022 | 56 | 0.740 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 518 | 0.740 |
Why?
|
| Hymecromone | 1 | 2021 | 10 | 0.730 |
Why?
|
| Hyaluronoglucosaminidase | 1 | 2021 | 27 | 0.730 |
Why?
|
| Nanofibers | 3 | 2025 | 15 | 0.690 |
Why?
|
| STAT3 Transcription Factor | 3 | 2022 | 233 | 0.690 |
Why?
|
| Antioxidants | 1 | 2023 | 333 | 0.660 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 225 | 0.650 |
Why?
|
| Mice | 26 | 2025 | 18507 | 0.640 |
Why?
|
| Mice, Inbred C57BL | 15 | 2025 | 4757 | 0.630 |
Why?
|
| Fetal Development | 3 | 2015 | 132 | 0.600 |
Why?
|
| Animals | 34 | 2025 | 34882 | 0.590 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2018 | 32 | 0.560 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 921 | 0.530 |
Why?
|
| NF-kappa B | 2 | 2018 | 454 | 0.510 |
Why?
|
| Hyperoxia | 1 | 2018 | 130 | 0.500 |
Why?
|
| Extracellular Matrix | 6 | 2020 | 238 | 0.480 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 7 | 0.480 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2015 | 20 | 0.480 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2015 | 323 | 0.470 |
Why?
|
| Signal Transduction | 3 | 2020 | 4703 | 0.470 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2018 | 211 | 0.470 |
Why?
|
| Dependovirus | 3 | 2013 | 153 | 0.470 |
Why?
|
| Pseudomonas Infections | 3 | 2022 | 116 | 0.460 |
Why?
|
| Cells, Cultured | 9 | 2025 | 3036 | 0.430 |
Why?
|
| Gene Expression | 1 | 2018 | 1558 | 0.420 |
Why?
|
| Cytomegalovirus | 1 | 2014 | 259 | 0.380 |
Why?
|
| Genetic Vectors | 2 | 2013 | 925 | 0.380 |
Why?
|
| Adenoviridae | 2 | 2015 | 595 | 0.370 |
Why?
|
| Viral Proteins | 1 | 2014 | 358 | 0.370 |
Why?
|
| Skin Ulcer | 1 | 2011 | 32 | 0.360 |
Why?
|
| Lung | 2 | 2018 | 1559 | 0.350 |
Why?
|
| Tissue Engineering | 2 | 2011 | 168 | 0.340 |
Why?
|
| Proteolysis | 1 | 2011 | 198 | 0.340 |
Why?
|
| Vagina | 2 | 2023 | 205 | 0.330 |
Why?
|
| Inflammation | 5 | 2025 | 1517 | 0.320 |
Why?
|
| Estrogens | 2 | 2023 | 435 | 0.310 |
Why?
|
| Wounds and Injuries | 2 | 2025 | 393 | 0.310 |
Why?
|
| Pulmonary Fibrosis | 2 | 2020 | 112 | 0.290 |
Why?
|
| Immune Tolerance | 2 | 2019 | 154 | 0.260 |
Why?
|
| Keratinocytes | 3 | 2016 | 62 | 0.250 |
Why?
|
| Cell Movement | 3 | 2015 | 889 | 0.250 |
Why?
|
| Endothelial Cells | 2 | 2025 | 527 | 0.250 |
Why?
|
| Hydrogels | 3 | 2025 | 108 | 0.240 |
Why?
|
| Endocardium | 1 | 2025 | 56 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 98 | 0.220 |
Why?
|
| Stress, Mechanical | 1 | 2025 | 173 | 0.220 |
Why?
|
| Pseudomonas aeruginosa | 3 | 2022 | 175 | 0.210 |
Why?
|
| Amnion | 1 | 2023 | 40 | 0.200 |
Why?
|
| Kidney | 2 | 2020 | 1331 | 0.200 |
Why?
|
| Bandages | 2 | 2020 | 56 | 0.200 |
Why?
|
| Molecular Weight | 2 | 2020 | 309 | 0.190 |
Why?
|
| Biofilms | 2 | 2022 | 98 | 0.190 |
Why?
|
| Inovirus | 1 | 2022 | 2 | 0.190 |
Why?
|
| Culture Media, Conditioned | 1 | 2022 | 83 | 0.190 |
Why?
|
| Propylene Glycol | 1 | 2021 | 9 | 0.180 |
Why?
|
| Administration, Cutaneous | 1 | 2021 | 67 | 0.180 |
Why?
|
| Dermis | 1 | 2021 | 26 | 0.180 |
Why?
|
| Collagen | 1 | 2023 | 308 | 0.180 |
Why?
|
| Gelatin | 1 | 2021 | 17 | 0.180 |
Why?
|
| Cytokines | 3 | 2025 | 1358 | 0.170 |
Why?
|
| Water | 1 | 2021 | 195 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 1 | 2021 | 397 | 0.170 |
Why?
|
| Skin Care | 1 | 2020 | 14 | 0.170 |
Why?
|
| Financing, Organized | 1 | 2020 | 22 | 0.170 |
Why?
|
| Ethanol | 1 | 2021 | 170 | 0.170 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 30 | 0.160 |
Why?
|
| Debridement | 1 | 2020 | 92 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2019 | 822 | 0.160 |
Why?
|
| Writing | 1 | 2020 | 66 | 0.160 |
Why?
|
| Humans | 21 | 2025 | 132062 | 0.160 |
Why?
|
| Gastrostomy | 1 | 2020 | 92 | 0.150 |
Why?
|
| Pseudomonas Phages | 1 | 2019 | 10 | 0.150 |
Why?
|
| Genetic Therapy | 2 | 2015 | 719 | 0.150 |
Why?
|
| Bleomycin | 1 | 2019 | 113 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 488 | 0.150 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 4688 | 0.140 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 270 | 0.140 |
Why?
|
| Herniorrhaphy | 1 | 2018 | 78 | 0.140 |
Why?
|
| Regeneration | 1 | 2020 | 226 | 0.140 |
Why?
|
| Phagocytosis | 1 | 2019 | 191 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2020 | 274 | 0.130 |
Why?
|
| Female | 12 | 2025 | 70712 | 0.130 |
Why?
|
| Cell Proliferation | 3 | 2020 | 2508 | 0.130 |
Why?
|
| Organ Culture Techniques | 2 | 2014 | 157 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 211 | 0.130 |
Why?
|
| Receptors, Notch | 1 | 2018 | 212 | 0.130 |
Why?
|
| Actins | 1 | 2018 | 334 | 0.120 |
Why?
|
| Cell Survival | 1 | 2018 | 865 | 0.120 |
Why?
|
| Macrophages | 1 | 2020 | 689 | 0.120 |
Why?
|
| Intestines | 1 | 2020 | 603 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 396 | 0.120 |
Why?
|
| Male | 7 | 2025 | 64922 | 0.120 |
Why?
|
| Transduction, Genetic | 2 | 2013 | 293 | 0.110 |
Why?
|
| Placental Insufficiency | 1 | 2015 | 15 | 0.110 |
Why?
|
| Myocardium | 1 | 2020 | 908 | 0.110 |
Why?
|
| Sex Factors | 1 | 2018 | 1353 | 0.110 |
Why?
|
| Allergens | 1 | 2017 | 276 | 0.110 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 67 | 0.100 |
Why?
|
| In Vitro Techniques | 1 | 2015 | 865 | 0.100 |
Why?
|
| Capillaries | 2 | 2011 | 71 | 0.100 |
Why?
|
| Palate | 1 | 2013 | 16 | 0.100 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2018 | 426 | 0.100 |
Why?
|
| Mouth Mucosa | 1 | 2013 | 49 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2015 | 791 | 0.100 |
Why?
|
| Algorithms | 1 | 2020 | 1728 | 0.100 |
Why?
|
| Skin Physiological Phenomena | 1 | 2013 | 17 | 0.100 |
Why?
|
| Fetal Growth Retardation | 1 | 2015 | 256 | 0.100 |
Why?
|
| Saliva | 1 | 2013 | 134 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2015 | 3863 | 0.090 |
Why?
|
| Parvoviridae Infections | 1 | 2012 | 37 | 0.090 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 271 | 0.090 |
Why?
|
| Viral Tropism | 1 | 2012 | 53 | 0.090 |
Why?
|
| Fetal Therapies | 1 | 2012 | 83 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 396 | 0.090 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 655 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2011 | 116 | 0.090 |
Why?
|
| Ointments | 2 | 2021 | 13 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1342 | 0.080 |
Why?
|
| Trachea | 1 | 2012 | 210 | 0.080 |
Why?
|
| Endothelium, Vascular | 2 | 2011 | 487 | 0.080 |
Why?
|
| Placenta | 1 | 2015 | 540 | 0.080 |
Why?
|
| Child Development | 1 | 2013 | 271 | 0.080 |
Why?
|
| Swine | 2 | 2025 | 1200 | 0.080 |
Why?
|
| Cystic Fibrosis | 1 | 2012 | 264 | 0.080 |
Why?
|
| Biomarkers | 2 | 2015 | 3406 | 0.070 |
Why?
|
| Apoptosis | 1 | 2015 | 1892 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3142 | 0.070 |
Why?
|
| Coculture Techniques | 2 | 2023 | 235 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2021 | 601 | 0.060 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8549 | 0.060 |
Why?
|
| Chorion | 1 | 2023 | 9 | 0.050 |
Why?
|
| Collagen Type VII | 1 | 2023 | 7 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2023 | 169 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 1694 | 0.050 |
Why?
|
| Pseudomonas | 1 | 2022 | 12 | 0.050 |
Why?
|
| Cell Nucleus | 2 | 2017 | 587 | 0.050 |
Why?
|
| Mammals | 1 | 2022 | 272 | 0.040 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2020 | 26 | 0.040 |
Why?
|
| Fetus | 2 | 2015 | 593 | 0.040 |
Why?
|
| Adoptive Transfer | 1 | 2021 | 238 | 0.040 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2020 | 19 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2023 | 728 | 0.040 |
Why?
|
| Immunocompetence | 1 | 2019 | 32 | 0.040 |
Why?
|
| Polyethylene Glycols | 1 | 2021 | 251 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2015 | 13028 | 0.040 |
Why?
|
| Abdomen | 1 | 2020 | 135 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 548 | 0.040 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2019 | 21 | 0.040 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2019 | 50 | 0.040 |
Why?
|
| Immunity | 1 | 2019 | 183 | 0.040 |
Why?
|
| Kinetics | 1 | 2020 | 1130 | 0.040 |
Why?
|
| Models, Animal | 1 | 2020 | 470 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2019 | 378 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 424 | 0.040 |
Why?
|
| Interferons | 1 | 2019 | 142 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 423 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 438 | 0.030 |
Why?
|
| Sulfhydryl Compounds | 1 | 2017 | 57 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 56 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2017 | 62 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 664 | 0.030 |
Why?
|
| Protein Transport | 1 | 2017 | 369 | 0.030 |
Why?
|
| Immunization | 1 | 2017 | 312 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2017 | 257 | 0.030 |
Why?
|
| Laparoscopy | 1 | 2020 | 523 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 1046 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 305 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 688 | 0.030 |
Why?
|
| Organ Size | 1 | 2015 | 449 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 448 | 0.030 |
Why?
|
| Middle Aged | 1 | 2014 | 28964 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2013 | 6 | 0.030 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 1 | 2013 | 5 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 2192 | 0.030 |
Why?
|
| Pneumonia | 1 | 2017 | 334 | 0.020 |
Why?
|
| Adult | 1 | 2014 | 31568 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2013 | 78 | 0.020 |
Why?
|
| Length of Stay | 1 | 2018 | 1379 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 104 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 1203 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2011 | 28 | 0.020 |
Why?
|
| Materials Testing | 1 | 2011 | 78 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2022 | 6567 | 0.020 |
Why?
|
| Pregnancy | 2 | 2015 | 7566 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 2445 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2013 | 271 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17419 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 142 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2011 | 78 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2011 | 200 | 0.020 |
Why?
|
| Heart | 1 | 2015 | 700 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 762 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 3091 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2011 | 206 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 309 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2558 | 0.020 |
Why?
|
| Cell Communication | 1 | 2010 | 187 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2013 | 1608 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1960 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 1224 | 0.020 |
Why?
|
| Adolescent | 2 | 2020 | 20562 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1033 | 0.020 |
Why?
|
| Liver | 1 | 2015 | 1797 | 0.020 |
Why?
|
| Child | 2 | 2020 | 25789 | 0.020 |
Why?
|
| Aged | 1 | 2023 | 21406 | 0.010 |
Why?
|
| Time Factors | 1 | 2010 | 6448 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 13064 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 14751 | 0.010 |
Why?
|